Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)

Conditions: SCLC, Limited Stage Interventions: Drug: Durvalumab; Drug: Chemotherapy drug of EP regimen; Radiation: radiotherapy Sponsors: Hebei Medical University Fourth Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials